Actavis Rumored To Be Close To Acquiring Allergan
November 17, 2014 at 10:40 AM EST
As per the sources, Actavis has agreed to pay $215 to $220 per share for the Botox maker.
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.